G. Ogilvie

发表

Energy expenditure in dogs with lymphoma fed two specialized diets

G. Ogilvie, L. Walters, M. Salman, 1993, Cancer.

Canine bladder and urethral tumors: a retrospective study of 115 cases (1980-1985).

G. Ogilvie, A. Norris, E. Laing, 1992, Journal of veterinary internal medicine.

Residential exposure to magnetic fields and risk of canine lymphoma.

J. Reif, G. Ogilvie, J S Reif, 1995, American journal of epidemiology.

Pathology of canine bladder and urethral cancer and correlation with tumour progression and survival.

G. Ogilvie, A. Norris, E. Laing, 1995, Journal of comparative pathology.

Nutrition and Cancer : Frontiers for Cure !

G. Ogilvie, 2006 .

Interventional nutrition for the cancer patient.

G. Ogilvie, 1998, Clinical techniques in small animal practice.

Ex vivo evaluation of imatinib mesylate for induction of cell death on canine neoplastic mast cells with mutations in c-Kit exon 11 via apoptosis

G. Rossi, C. Bertani, G. Ogilvie, 2013, Veterinary Research Communications.

The Histologic Classification of 602 Cases of Feline Lymphoproliferative Disease using the National Cancer Institute Working Formulation

C. Couto, G. Ogilvie, V. Valli, 2000, Journal of veterinary diagnostic investigation : official publication of the American Association of Veterinary Laboratory Diagnosticians, Inc.

Chapter 11 – Oncologic Diseases of the Digestive System

G. Ogilvie, N. Leibman, V. Larson, 2003 .

Alterations in carbohydrate metabolism in canine lymphoma.

G. Ogilvie, S. Wheeler, M. J. Fettman, 1990, Journal of veterinary internal medicine.

99mTc‐METHOXY‐ISOBUTYL‐ISONITRILE (SESTAMIBI) IMAGING OF MALIGNANT CANINE LYMPHOMA

G. Ogilvie, P. Steyn, 1995 .

Classification of primary lung tumors in dogs: 210 cases (1975-1985).

W. Haschek, G. Ogilvie, A. Norris, 1989, Journal of the American Veterinary Medical Association.

Cyclooxygenase-2 expression in canine appendicular osteosarcomas.

G. Ogilvie, S. Withrow, S. Lana, 2004, Journal of veterinary internal medicine.

Streptozocin for treatment of pancreatic islet cell tumors in dogs: 17 cases (1989-1999).

G. Ogilvie, R. Nelson, C. Henry, 2002, Journal of the American Veterinary Medical Association.

Alterations in lipoprotein profiles in dogs with lymphoma.

G. Ogilvie, L. Walters, M. J. Fettman, 1994, Journal of veterinary internal medicine.

Effects of chemotherapy and remission on carbohydrate metabolism in dogs with lymphoma

G. Ogilvie, S. Wheeler, M. J. Fettman, 1992, Cancer.

18 – COMPLEMENTARY AND ALTERNATIVE CANCER THERAPY: CURE OR QUACKERY?

G. Ogilvie, 2001 .

Masitinib - a targeted therapy with applications in veterinary oncology and inflammatory diseases.

G. Ogilvie, 2011 .

Interleukins: biological properties and therapeutic potential.

G. Ogilvie, S. Dow, R. Elmslie, 1991, Journal of veterinary internal medicine.

Exacerbation of hyperlactatemia by infusion of lactated Ringer's solution in dogs with lymphoma.

G. Ogilvie, S. Wheeler, M. J. Fettman, 1990, Journal of veterinary internal medicine.

Cardiac troponin I in canine patients with lymphoma and osteosarcoma receiving doxorubicin: comparison with clinical heart disease in a retrospective analysis.

G. Ogilvie, M. J. Fettman, S. Lana, 2004, Veterinary and comparative oncology.

Chemotherapy and the surgery patient: principles and recent advances.

G. Ogilvie, Gregory K. Ogilvie, 1998, Clinical techniques in small animal practice.

Phase I evaluation of mitoxantrone alone and combined with whole body hyperthermia in dogs with lymphoma.

M. Dewhirst, G. Ogilvie, D. Thrall, 1996, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

THE NON‐CARDIAC DISTRIBUTION OF 99mTC‐METHOXY‐ISOBUTYL‐ISONITRILE (SESTAMIBI) IN NORMAL BEAGLES

G. Ogilvie, P. Steyn, 1995 .

A Clinician's Viewpoints on Wellness and the Human-Animal Bond in Practice

G. Ogilvie, 2016 .

Use of recombinant canine granulocyte colony-stimulating factor to decrease myelosuppression associated with the administration of mitoxantrone in the dog.

T. Boone, G. Ogilvie, L. Walters, 1992, Journal of veterinary internal medicine.

Dietary long-chain n-3 fatty acids modify blood and cardiac phospholipids and reduce protein kinase-C-δ and protein kinase-C-ε translocation

G. Ogilvie, C. Couet, P. Champéroux, 2007, British Journal of Nutrition.

Matrix metalloproteinase activity in tumor, stromal tissue, and serum from cats with malignancies.

G. Ogilvie, M. J. Fettman, B. Powers, 2002, Journal of veterinary internal medicine.

Application of rapid CD3 immunophenotype analysis and argyrophilic nucleolar organizer region (AgNOR) frequency to fine needle aspirate specimens from dogs with lymphoma.

G. Ogilvie, W. Kisseberth, D. Vail, 1997, Veterinary clinical pathology.

Evaluation of recombinant canine granulocyte colony-stimulating factor as an inducer of granulopoiesis. A pilot study.

T. Boone, G. Ogilvie, B. Powers, 1991, Journal of veterinary internal medicine.

Nutrition and cancer. Recent developments.

G. Ogilvie, D. Vail, 1990, The Veterinary clinics of North America. Small animal practice.

Induction of IL-2 and lymphokine activated killer cells in the cat.

W. Tompkins, R. Franklin, K. Kelley, 1987, Veterinary immunology and immunopathology.

Feline Oncology: A Comprehensive Guide to Compassionate Care

G. Ogilvie, A. Moore, 2001 .

Doxorubicin and BAY 12-9566 for the treatment of osteosarcoma in dogs: a randomized, double-blind, placebo-controlled study.

G. Ogilvie, B. Powers, B. Kitchell, 2007, Journal of veterinary internal medicine.

Treatment of thyroid carcinoma in dogs by surgical resection alone: 20 cases (1981-1989).

G. Ogilvie, B. Powers, S. Withrow, 1995, Journal of the American Veterinary Medical Association.

Enhanced radiosensitivity of rat autochthonous mammary tumors by dietary docosahexaenoic acid

G. Ogilvie, P. Bougnoux, C. Hoinard, 2004, International journal of cancer.

Actinomycin D for reinduction of remission in dogs with resistant lymphoma.

G. Ogilvie, D. Vail, A. Moore, 1994, Journal of veterinary internal medicine.

Increased Lactate Concentrations in III and Injured Dogs

G. Ogilvie, T. Hackett, W. Wingfield, 1998 .

Lactate Kinetics in veterinary Critical Care: A Review

G. Ogilvie, T. Hackett, W. Wingfield, 1996 .

Clinical and immunologic aspects of FeLV-induced immunosuppression.

W. Tompkins, G. Ogilvie, M. Tompkins, 1988, Veterinary microbiology.

Hematologic improvement in dogs with parvovirus infection treated with recombinant canine granulocyte-colony stimulating factor.

G. Ogilvie, S. Dow, T. Hackett, 2010, Journal of veterinary pharmacology and therapeutics.

Ethics and compassionate cancer care: where do we draw the line?

G. Ogilvie, 2008, Compendium.

Endocrine Manifestations of Malignancy in Cats*

G. Ogilvie, 2005 .

Canine primary renal neoplasms: a retrospective review of 54 cases

G. Ogilvie, A. Norris, S. Withrow, 1988 .

Efficacy of mitoxantrone against various neoplasms in dogs.

G. Ogilvie, S. Withrow, D. Vail, 1991, Journal of the American Veterinary Medical Association.

Phase II evaluation of doxorubicin for treatment of various canine neoplasms.

G. Ogilvie, A. Norris, S. Withrow, 1989, Journal of the American Veterinary Medical Association.

Surgery and doxorubicin in dogs with hemangiosarcoma.

G. Ogilvie, B. Powers, C. Mallinckrodt, 1996, Journal of veterinary internal medicine.

Clinical outcome of dogs with grade-II mast cell tumors treated with surgery alone: 55 cases (1996-1999).

G. Ogilvie, M. J. Fettman, B. Séguin, 2001, Journal of the American Veterinary Medical Association.

Response of canine mast cell tumors to treatment with oral prednisone.

F. W. Bell, M. Miller, G. Ogilvie, 1994, Journal of veterinary internal medicine.

Use of radionuclide imaging to identify malignant mammary tumor bone metastases in dogs.

G. Ogilvie, R. V. Allhands, H. Reynolds, 1989, Journal of the American Veterinary Medical Association.

Effects of diet on pharmacokinetics of phenobarbital in healthy dogs.

G. Ogilvie, A. Turner, D. Greco, 2000, Journal of the American Veterinary Medical Association.

Toxicoses and efficacy associated with administration of mitoxantrone to cats with malignant tumors.

G. Ogilvie, D. Vail, R. Elmslie, 1993, Journal of the American Veterinary Medical Association.

RADIOTHERAPY WITH AND WITHOUT CHEMOTHERAPY FOR LOCALIZED LYMPHOMA IN 10 CATS

G. Ogilvie, E. Gillette, R. Elmslie, 1991 .

Effect of omega-3 fatty acids on canine atopic dermatitis.

G. Ogilvie, M. J. Fettman, R. Rosychuk, 2004, The Journal of small animal practice.

Thymoma in dogs: 23 cases (1980-1991).

G. Ogilvie, B. Powers, S. Withrow, 1994, Journal of the American Veterinary Medical Association.

Short-term effect of cyclophosphamide and azathioprine on selected aspects of the canine blastogenic response.

G. Ogilvie, P. Felsburg, C. W. Harris, 1988, Veterinary immunology and immunopathology.

Monoclonal antibody C219 immunohistochemistry against P-glycoprotein: sequential analysis and predictive ability in dogs with lymphoma.

G. Ogilvie, B. Powers, P. Bergman, 1996, Journal of veterinary internal medicine.

Phase I evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma.

G. Ogilvie, S. Withrow, D. Thrall, 1992, Journal of veterinary internal medicine.

Cancer Institute Working Formulation The Histologic Classification of 602 Cases of Feline Lymphoproliferative Disease using the National

C. Couto, G. Ogilvie, V. Valli, 2013 .

Canine and feline nasal and paranasal sinus tumors.

G. Ogilvie, S. LaRue, S M LaRue, 1992, The Veterinary clinics of North America. Small animal practice.

Single agent chemotherapy with doxorubicin for feline lymphoma: a retrospective study of 19 cases (1994-1997).

W. Rand, G. Ogilvie, S. Lana, 2001, Journal of veterinary internal medicine.

Cytology of canine malignant histiocytosis.

G. Ogilvie, M. Thrall, D. Getzy, 1994, Veterinary clinical pathology.

Plasma and skin concentrations of polyunsaturated fatty acids before and after supplementation with n-3 fatty acids in dogs with atopic dermatitis.

G. Ogilvie, M. J. Fettman, R. Mueller, 2005, American journal of veterinary research.

Ocular disease in FeLV-positive cats: 11 cases (1981-1986).

G. Ogilvie, A. Brightman, M. Tompkins, 1991, Journal of the American Veterinary Medical Association.

Feline lymphoma (145 cases): proliferation indices, cluster of differentiation 3 immunoreactivity, and their association with prognosis in 90 cats.

G. Ogilvie, D. Vail, A. Moore, 1998, Journal of veterinary internal medicine.

Canine digital tumors: a veterinary cooperative oncology group retrospective study of 64 dogs.

G. Ogilvie, D. Vail, E. Whitley, 2005, Journal of veterinary internal medicine.

Cimetidine for treatment of melanomas in three horses.

K. Keegan, G. Ogilvie, P. J. Johnson, 1990, Journal of the American Veterinary Medical Association.

Clinical management of progressive multifocal benign and malignant melanomas of horses with oral cimetidine.

G. Ogilvie, T. Goetz, C. Boulton, 1990 .

Salivary gland neoplasia in the dog and cat: survival times and prognostic factors.

G. Ogilvie, W. Kisseberth, A Hammer, 2001, Journal of the American Animal Hospital Association.

Recent advances in the treatment of vaccine-associated sarcomas.

G. Ogilvie, 2001, The Veterinary clinics of North America. Small animal practice.

Histologically low-grade, yet biologically high-grade, fibrosarcomas of the mandible and maxilla in dogs: 25 cases (1982-1991).

G. Ogilvie, B. Powers, S. Withrow, 1994, Journal of the American Veterinary Medical Association.

Squamous cell carcinoma of the tongue in 10 dogs

P. Schwarz, G. Ogilvie, B. Powers, 1993 .

Evaluation of 12- and 24-month survival rates after treatment with masitinib in dogs with nonresectable mast cell tumors.

J. Kinet, P. Dubreuil, G. Ogilvie, 2010, American journal of veterinary research.

Generalized demodicosis associated with diabetes mellitus in two cats.

G. Ogilvie, S. White, F. Moore, 1987, Journal of the American Veterinary Medical Association.

Prognosis for dogs with nonlymphomatous, small intestinal tumors treated by surgical excision.

W M Rand, W. Rand, G. Ogilvie, 1998, Journal of the American Animal Hospital Association.

Feline cutaneous squamous cell carcinoma of the nasal planum and the pinnae: 61 cases.

G. Ogilvie, S. Withrow, S. Lana, 1997, Journal of the American Animal Hospital Association.

Care Beyond a Cure : Extraordinary Advances in Cancer Care 2014

G. Ogilvie, Diplomate Acvim, 2014 .

Response of feline oral squamous cell carcinoma to palliative radiation therapy.

G. Ogilvie, M. J. Fettman, B. Powers, 2001, Veterinary radiology & ultrasound : the official journal of the American College of Veterinary Radiology and the International Veterinary Radiology Association.

Evaluation of prognostic factors for dogs with primary lung tumors: 67 cases (1985-1992).

G. Ogilvie, B. Powers, S. Withrow, 1997, Journal of the American Veterinary Medical Association.

KEY FACTS Emergency Complications Associated with Chemotherapeutics and Cancer

G. Ogilvie, T. Hackett, Michael Walters, 2005 .

Papillary squamous cell carcinoma in three young dogs.

J. Sundberg, M. O’Banion, G. Ogilvie, 1988, Journal of the American Veterinary Medical Association.

Retrospective study of 26 primary tumors of the osseous thoracic wall in dogs

R. Montgomery, G. Ogilvie, A. Norris, 1993 .

Evaluation of dogs and cats with tumors of the ear canal: 145 cases (1978-1992).

G. Ogilvie, A. Norris, D. McCaw, 1996, Journal of the American Veterinary Medical Association.

Prognostic factors for tumor remission and survival in dogs after surgery for primary lung tumor: 76 cases (1975-1985).

R. Weigel, W. Haschek, G. Ogilvie, 1989, Journal of the American Veterinary Medical Association.

Platelet hyperfunction in dogs with malignancies.

G. Ogilvie, M. J. Fettman, M. Salman, 1997, Journal of veterinary internal medicine.

Resistance to Ehrlich ascites tumor in a strain of dystrophic mice.

G. Ogilvie, P. Carry, D. Prescott, 1979, Cancer Research.

Managing the Veterinary Cancer Patient: A Practice Manual

G. Ogilvie, A. Moore, 1997 .

Frequency of argyrophilic nucleolar organizer regions in fine-needle aspirates and biopsy specimens from mast cell tumors in dogs.

G. Ogilvie, W. Kisseberth, D. Vail, 1996, Journal of the American Veterinary Medical Association.

Acute and short-term toxicoses associated with the administration of doxorubicin to dogs with malignant tumors.

G. Ogilvie, A. Norris, S. Withrow, 1989, Journal of the American Veterinary Medical Association.

Masitinib is safe and effective for the treatment of canine mast cell tumors.

J. Kinet, P. Dubreuil, P. S. Leventhal, 2008, Journal of veterinary internal medicine.

Evaluation of single-agent chemotherapy for treatment of clinically evident osteosarcoma metastases in dogs: 45 cases (1987-1991).

G. Ogilvie, L. Walters, B. Powers, 1993, Journal of the American Veterinary Medical Association.

Amputation and cisplatin for treatment of canine osteosarcoma.

G. Ogilvie, B. Powers, S. Withrow, 1991, Journal of veterinary internal medicine.

Evaluation of a short-term saline diuresis protocol for the administration of cisplatin.

A. R. Twardock, G. Ogilvie, H. Gelberg, 1988, American journal of veterinary research.

Metabolic alterations in dogs with osteosarcoma.

G. Ogilvie, M. J. Fettman, T. Stein, 2001, American journal of veterinary research.

Resting energy expenditure in dogs with nonhematopoietic malignancies before and after excision of tumors.

G. Ogilvie, L. Walters, M. J. Fettman, 1996, American Journal of Veterinary Research.

Resection of pulmonary metastases in canine osteosarcoma: 36 cases (1983-1992).

G. Ogilvie, B. Powers, S. Withrow, 1993, Veterinary surgery : VS.

Prophylactic trimethoprim-sulfadiazine during chemotherapy in dogs with lymphoma and osteosarcoma: a double-blind, placebo-controlled study.

G. Ogilvie, N. Shaw, N. Northrup, 2007, Journal of veterinary internal medicine.

Identification of matrix metalloproteinases in canine neoplastic tissue.

G. Ogilvie, B. Powers, S. Withrow, 2000, American journal of veterinary research.

Prevalence of nephrotoxicosis associated with a four-hour saline solution diuresis protocol for the administration of cisplatin to dogs with naturally developing neoplasms.

G. Ogilvie, L. Walters, B. Powers, 1993, Journal of the American Veterinary Medical Association.

Prevalence of nephrotoxicosis associated with a short-term saline solution diuresis protocol for the administration of cisplatin to dogs with malignant tumors: 61 cases (1987-1989).

G. Ogilvie, B. Powers, S. Withrow, 1991, Journal of the American Veterinary Medical Association.

Chapter 24 – BONE TUMORS

G. Ogilvie, 2001 .

The effect of levothyroxine treatment on resting energy expenditure of hypothyroid dogs.

G. Ogilvie, R. Rosychuk, D. Greco, 1998, Journal of veterinary internal medicine.

Energy Expenditure in 104 Postoperative and Traumatically Injured Dogs with Indirect Calorimetry

G. Ogilvie, M. J. Fettman, W. Wingfield, 1996 .

Evaluation of cisplatin-induced emesis in dogs with malignant neoplasia: 115 cases (1984-1987).

G. Ogilvie, A. Moore, C. Curtis, 1989, Journal of the American Veterinary Medical Association.

Menhaden oil administration to dogs treated with radiation for nasal tumors demonstrates lower levels of tissue eicosanoids.

G. Ogilvie, M. J. Fettman, S. LaRue, 2011, Nutrition research.

Identification of matrix metalloproteinases in canine cutaneous mast cell tumors.

G. Ogilvie, M. J. Fettman, B. Powers, 2000, Journal of veterinary internal medicine.

Passive smoking and canine lung cancer risk.

J. Reif, G. Ogilvie, C. K. Harris, 1992, American journal of epidemiology.

Toxicoses associated with administration of mitoxantrone to dogs with malignant tumors.

G. Ogilvie, S. Withrow, D. Vail, 1991, Journal of the American Veterinary Medical Association.

Characterization and evaluation of a new oncolytic Vaccinia Virus strain LIVP6.1.1 for canine cancer therapy

G. Ogilvie, Yong A. Yu, Qian Zhang, 2013, Bioengineered.

Thyroid hormone concentrations in dogs with chronic weight loss, with special reference to cancer cachexia.

G. Ogilvie, D. Vail, D. Panciera, 1994, Journal of veterinary internal medicine.

Resolution of paraneoplastic leukocytosis and hypertrophic osteopathy after resection of a renal transitional cell carcinoma producing granulocyte-macrophage colony-stimulating factor in a young Bull Terrier.

F. Snaps, G. Ogilvie, C. Clercx, 2001, Journal of veterinary internal medicine.

Effects of plasma sample storage on blood ammonia, bilirubin, and urea nitrogen concentrations: cats and horses.

M. Anwer, G. Ogilvie, L. Engelking, 1985, American journal of veterinary research.

Serum Alpha 1-Acid Glycoprotein Concentrations in Healthy and Tumor-Bearing Cats

G. Ogilvie, M. J. Fettman, S. Lana, 2000 .

Doxorubicin alone or in combination with asparaginase, followed by cyclophosphamide, vincristine, and prednisone for treatment of multicentric lymphoma in dogs: 121 cases (1987-1995).

G. Ogilvie, C. Mallinckrodt, K. Valerius, 1997, Journal of the American Veterinary Medical Association.

Hematopoietic growth factors: frontiers for cure.

G. Ogilvie, Gregory K. Ogilvie, 1995, The Veterinary clinics of North America. Small animal practice.

Oncolytic virotherapy in veterinary medicine: current status and future prospects for canine patients

I. Nolte, G. Ogilvie, I. Gentschev, 2012, Journal of Translational Medicine.

Performance of a multi-sector ultrasound hyperthermia applicator and control system: in vivo studies.

E. Burdette, S. Goss, G. Ogilvie, 1990, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Effect of recombinant canine granulocyte colony-stimulating factor on peripheral blood neutrophil counts in normal cats.

T. Boone, G. Ogilvie, S. Stadler-Morris, 1993, Journal of veterinary internal medicine.

Phase III evaluation of doxorubicin and whole-body hyperthermia in dogs with lymphoma.

G. Rosner, G. Ogilvie, S. Withrow, 1992, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Modulation of canine lymphocyte blastogenesis via histamine.

G. Ogilvie, P. Felsburg, S. Daniel, 1990, Veterinary immunology and immunopathology.

Evaluation of novel serological markers and autoantibodies in dogs with inflammatory bowel disease

Benjamin J Polansky, D. Barken, G. Ogilvie, 2020, Journal of veterinary internal medicine.

Serum zinc, chromium, and iron concentrations in dogs with lymphoma and osteosarcoma.

G. Ogilvie, M. J. Fettman, S. Lana, 2001, Journal of veterinary internal medicine.

Platelet function in dogs treated for lymphoma and hemangiosarcoma and supplemented with dietary n-3 fatty acids.

G. Ogilvie, M. J. Fettman, C. Mallinckrodt, 1999, Journal of veterinary internal medicine.

Alterations in carbohydrate metabolism in dogs with nonhematopoietic malignancies.

G. Ogilvie, L. Walters, M. J. Fettman, 1997, American Journal of Veterinary Research.

Metabolic alterations in patients with cancer cachexia.

G. Ogilvie, S. Wheeler, D. Vail, 1990 .

Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma

G. Ogilvie, M. J. Fettman, M. Hand, 2000, Cancer.

Canine Digital Tumors: A Veterinary Cooperative Oncology Group Retrospective Study of 64 Dogs

G. Ogilvie, A. Norris, D. Vail, 2005 .

Effects of dietary flaxseed oil supplementation on equine plasma fatty acid concentrations and whole blood platelet aggregation.

J. Traub-Dargatz, G. Ogilvie, M. J. Fettman, 2002, Journal of veterinary internal medicine.

Polyunsaturated Fatty Acid Dietary Supplementation Induces Lipid Peroxidation in Normal Dogs

G. Ogilvie, M. J. Fettman, T. Hackett, 2010, Veterinary medicine international.

Fish oil decreases matrix metalloproteinases in knee synovia of dogs with inflammatory joint disease.

G. Pluhar, G. Ogilvie, M. J. Fettman, 2008, The Journal of nutritional biochemistry.

CARE BEYOND A CURE: ONCOLOGIC EMERGENCIES-HELP!!!!

G. Ogilvie, 2005 .

Concentration of alpha 1-acid glycoprotein in dogs with malignant neoplasia.

G. Ogilvie, L. Walters, M. Salman, 1993, Journal of the American Veterinary Medical Association.

CyberKnife stereotactic radiotherapy for treatment of primary intracranial tumors in dogs

G. Ogilvie, Lenore A Mohammadian, Gabrielle L Carter, 2021, Journal of veterinary internal medicine.

Understanding compassion fatigue: keys for the caring veterinary healthcare team.

G. Ogilvie, K. Mitchener, 2002, Journal of the American Animal Hospital Association.

Evaluation of the effects of dietary n-3 fatty acid supplementation on the pharmacokinetics of doxorubicin in dogs with lymphoma.

G. Ogilvie, M. J. Fettman, D. Gustafson, 2006, American journal of veterinary research.

Dolasetron: a new option for nausea and vomiting.

G. Ogilvie, 2000, The Journal of the American Animal Hospital Association.

Weekly administration of low-dose doxorubicin for treatment of malignant lymphoma in dogs.

G. Ogilvie, B. Powers, D. Vail, 1991, Journal of the American Veterinary Medical Association.

Paraneoplastic syndromes.

G. Ogilvie, 1998, The Veterinary clinics of North America. Equine practice.

Tumour cell kinetics as predictors of response in canine lymphoma treated with chemotherapy alone or combined with whole body hyperthermia.

M. Dewhirst, G. Ogilvie, S. LaRue, 1999, International journal of hyperthermia : the official journal of European Society for Hyperthermic Oncology, North American Hyperthermia Group.

Disseminated meningeal tumor in a dog.

G. Ogilvie, G. Daniel, J. L. Dorner, 1987, Journal of the American Veterinary Medical Association.

Evaluation of a one-hour saline diuresis protocol for administration of cisplatin to dogs.

G. Ogilvie, L. Walters, M. J. Fettman, 1992, American journal of veterinary research.

Oncologic pain in dogs: prevention and treatment

G. Ogilvie, A. Moore, 2006 .